Literature DB >> 17188510

Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells.

Hironao Saegusa1, Minoru Wakamori, Yoshihiro Matsuda, Junyang Wang, Yasuo Mori, Shuqin Zong, Tsutomu Tanabe.   

Abstract

Spinocerebellar ataxia type 6 (SCA6) is caused by polyglutamine expansion in P/Q-type Ca2+ channels (Ca(v)2.1) and is characterized by predominant degeneration of cerebellar Purkinje cells. To characterize the Ca(v)2.1 channel with an SCA6 mutation in cerebellar Purkinje cells, we have generated knock-in mouse models that express human Ca(v)2.1 with 28 polyglutamine repeats (disease range) and with 13 polyglutamine repeats (normal range). Patch-clamp recordings of the Purkinje cells from homozygous control or SCA6 knock-in mice revealed a non-inactivating current that is highly sensitive to a spider toxin omega-Agatoxin IVA, indicating that the human Ca(v)2.1 expressed in Purkinje cells exhibits typical P-type properties in contrast to the previous data showing Q-type properties, when it was expressed in cultured cell lines. Furthermore, the voltage dependence of activation and inactivation and current density were not different between SCA6 and control, though these properties were altered in previous reports using non-neuronal cells as expression systems. Therefore, our results do not support the notion that the alteration of the channel properties may underlie the pathogenic mechanism of SCA6.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188510     DOI: 10.1016/j.mcn.2006.11.006

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  30 in total

1.  Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels.

Authors:  Yoshitsugu Uriu; Shigeki Kiyonaka; Takafumi Miki; Masakuni Yagi; Satoshi Akiyama; Emiko Mori; Akito Nakao; Aaron M Beedle; Kevin P Campbell; Minoru Wakamori; Yasuo Mori
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia.

Authors:  Sascha Vermeer; Alexander Hoischen; Rowdy P P Meijer; Christian Gilissen; Kornelia Neveling; Nienke Wieskamp; Arjan de Brouwer; Michel Koenig; Mathieu Anheim; Mirna Assoum; Nathalie Drouot; Slobodanka Todorovic; Vedrana Milic-Rasic; Hanns Lochmüller; Giovanni Stevanin; Cyril Goizet; Albert David; Alexandra Durr; Alexis Brice; Berry Kremer; Bart P C van de Warrenburg; Mascha M V A P Schijvenaars; Angelien Heister; Michael Kwint; Peer Arts; Jenny van der Wijst; Joris Veltman; Erik-Jan Kamsteeg; Hans Scheffer; Nine Knoers
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 3.  Genetically engineered mouse models of the trinucleotide-repeat spinocerebellar ataxias.

Authors:  Melissa A C Ingram; Harry T Orr; H Brent Clark
Journal:  Brain Res Bull       Date:  2011-07-23       Impact factor: 4.077

Review 4.  The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.

Authors:  Ravi Chopra; Vikram G Shakkottai
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

5.  An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron.

Authors:  Yu Miyazaki; Xiaofei Du; Shin-Ichi Muramatsu; Christopher M Gomez
Journal:  Sci Transl Med       Date:  2016-07-13       Impact factor: 17.956

6.  Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.

Authors:  Carlo Bavassano; Andreas Eigentler; Ruslan Stanika; Gerald J Obermair; Sylvia Boesch; Georg Dechant; Roxana Nat
Journal:  Stem Cells Dev       Date:  2017-10-30       Impact factor: 3.272

7.  Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6.

Authors:  Parviz Daniel Hejazi Pastor; Xiaofei Du; Sarah Fazal; Andre N Davies; Christopher M Gomez
Journal:  Cerebellum       Date:  2018-02       Impact factor: 3.847

8.  Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.

Authors:  Kei Watase; Curtis F Barrett; Taisuke Miyazaki; Taro Ishiguro; Kinya Ishikawa; Yuanxin Hu; Toshinori Unno; Yaling Sun; Sayumi Kasai; Masahiko Watanabe; Christopher M Gomez; Hidehiro Mizusawa; Richard W Tsien; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

Review 9.  Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias.

Authors:  Antoni Matilla-Dueñas; Ivelisse Sánchez; Marc Corral-Juan; Antoni Dávalos; Ramiro Alvarez; Pilar Latorre
Journal:  Cerebellum       Date:  2010-06       Impact factor: 3.847

10.  The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.

Authors:  Taro Ishiguro; Kinya Ishikawa; Makoto Takahashi; Masato Obayashi; Takeshi Amino; Nozomu Sato; Masaki Sakamoto; Hiroto Fujigasaki; Fuminori Tsuruta; Ricardo Dolmetsch; Takao Arai; Hidenao Sasaki; Kazuro Nagashima; Takeo Kato; Mitsunori Yamada; Hitoshi Takahashi; Yoshio Hashizume; Hidehiro Mizusawa
Journal:  Acta Neuropathol       Date:  2009-12-31       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.